[go: up one dir, main page]

BRPI0914889A2 - peptídeo glp-1 adicionado de cadeia oligossacarídica - Google Patents

peptídeo glp-1 adicionado de cadeia oligossacarídica

Info

Publication number
BRPI0914889A2
BRPI0914889A2 BRPI0914889A BRPI0914889A BRPI0914889A2 BR PI0914889 A2 BRPI0914889 A2 BR PI0914889A2 BR PI0914889 A BRPI0914889 A BR PI0914889A BR PI0914889 A BRPI0914889 A BR PI0914889A BR PI0914889 A2 BRPI0914889 A2 BR PI0914889A2
Authority
BR
Brazil
Prior art keywords
peptide
oligosaccharide chain
chain added
added glp
glp
Prior art date
Application number
BRPI0914889A
Other languages
English (en)
Inventor
Hiroaki Asai
Izumi Sakamoto
Katsunari Tezuka
Kazuhiro Fukae
Kazuyuki Ishii
Naohiro Hayashi
Takashi Tsuji
Yasuhiro Kajihara
Yuri Nambu
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of BRPI0914889A2 publication Critical patent/BRPI0914889A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0914889A 2008-06-17 2009-06-15 peptídeo glp-1 adicionado de cadeia oligossacarídica BRPI0914889A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008157583 2008-06-17
JP2008326609 2008-12-22
PCT/JP2009/002709 WO2009153960A1 (ja) 2008-06-17 2009-06-15 糖鎖付加ｇｌｐ－１ペプチド

Publications (1)

Publication Number Publication Date
BRPI0914889A2 true BRPI0914889A2 (pt) 2015-11-24

Family

ID=41433882

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914889A BRPI0914889A2 (pt) 2008-06-17 2009-06-15 peptídeo glp-1 adicionado de cadeia oligossacarídica

Country Status (11)

Country Link
US (1) US8765669B2 (pt)
EP (1) EP2298801A4 (pt)
JP (1) JP5604297B2 (pt)
KR (1) KR101609005B1 (pt)
CN (1) CN102083854A (pt)
AU (1) AU2009261441B2 (pt)
BR (1) BRPI0914889A2 (pt)
CA (1) CA2727147A1 (pt)
RU (1) RU2543157C2 (pt)
TW (1) TWI459960B (pt)
WO (1) WO2009153960A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870728A (zh) 2009-04-23 2010-10-27 派格生物医药(苏州)有限公司 新型Exendin变体及其缀合物
BR112012011467A2 (pt) * 2009-10-30 2019-09-24 Otsuka Chemical Co Ltd forma glicosilada de análogo ao glp-1 antigênico.
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US9234023B2 (en) * 2010-06-24 2016-01-12 Biousian Biosystems, Inc. Glucagon-like peptide-1 glycopeptides
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
CN102718858B (zh) * 2011-03-29 2014-07-02 天津药物研究院 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
RU2627184C2 (ru) 2011-09-04 2017-08-03 Глитек, Инк. Гликозилированные полипептиды и лекарственные композиции, содержащие данные полипептиды
BR112014004784A2 (pt) * 2011-09-04 2017-03-21 Glytech Inc polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
SG10201602076QA (en) * 2011-10-01 2016-04-28 Glytech Inc Glycosylated polypeptide and pharmaceutical composition containing same
NZ630848A (en) 2012-06-08 2016-07-29 Alkermes Inc Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
WO2014064215A1 (en) 2012-10-24 2014-05-01 INSERM (Institut National de la Santé et de la Recherche Médicale) TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
DK2924053T3 (da) 2012-11-22 2020-12-14 Glytech Inc Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf
JP6219308B2 (ja) * 2012-11-30 2017-10-25 株式会社糖鎖工学研究所 糖鎖付加リンカー、糖鎖付加リンカーと生理活性物質とを含む化合物またはその塩、及びそれらの製造方法
CA2894765A1 (en) 2012-12-21 2014-06-26 Sanofi Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
DK2982686T3 (en) * 2013-03-29 2018-10-08 Glytech Inc POLYPEPTIDE WITH SIALYLED SUGAR CHAIN CONNECTED
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
ES2805743T3 (es) 2015-03-24 2021-02-15 Inst Nat Sante Rech Med Método y composición farmacéutica para uso en el tratamiento de la diabetes
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
JP2019218265A (ja) * 2016-09-14 2019-12-26 生化学工業株式会社 ペプチドの血中滞留性を増強させる方法
CN109021093B (zh) * 2018-08-29 2021-09-07 上海生物制品研究所有限责任公司 聚乙二醇修饰的glp-1衍生物及其药用盐
CN115417914B (zh) * 2019-10-11 2024-10-01 润辉生物技术（威海）有限公司 一种乙酰透明质酸寡肽及其制备与应用方法
AU2020394444B2 (en) 2019-11-25 2025-05-29 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
EP4314073A4 (en) 2021-03-24 2025-02-19 Alkermes, Inc. Upar antibodies and fusion proteins with the same
WO2022239839A1 (ja) * 2021-05-13 2022-11-17 学校法人東京理科大学 糖鎖修飾神経ペプチド誘導体、医薬組成物、経鼻・点鼻製剤及び医薬組成物の使用
CN115215948B (zh) * 2022-06-02 2023-07-11 润辉生物技术（威海）有限公司 一种低分子的乙酰透明质酸脱羧肌肽衍生物、制备方法及应用
KR20250106286A (ko) * 2022-11-10 2025-07-09 갓코호우징 도쿄리카다이가쿠 신경 펩타이드 서열 및 당쇄를 포함하는 당쇄 수식 신경 펩타이드 유도체, 의약 조성물, 경비·점비 제제 및 당쇄 수식 신경 펩타이드 유도체의 사용
EP4617289A1 (en) * 2022-11-10 2025-09-17 Glytech, Inc. Physiologically-active peptide derivative for treatment of eye diseases, pharmaceutical composition, nasal/nasal drop preparation, and use of physiologically-active peptide derivative

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277819B1 (en) 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
UA65549C2 (uk) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
SE9802080D0 (sv) 1998-06-11 1998-06-11 Hellstroem Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
MY155270A (en) 1998-09-24 2015-09-30 Lilly Co Eli Use of glp-1 or analogs in treatment of stroke
CN1234414C (zh) * 2000-03-17 2006-01-04 味之素株式会社 糖尿病性合并症和神经障碍用的药剂及其应用
KR100885149B1 (ko) * 2001-06-19 2009-02-23 오츠카 가가쿠 가부시키가이샤 당쇄 아스파라긴 유도체의 제조 방법
US7265085B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycoconjugation methods and proteins/peptides produced by the methods
US7943763B2 (en) 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
TWI335920B (en) 2002-12-24 2011-01-11 Yasuhiro Kajihara Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof
CN100378128C (zh) 2002-12-26 2008-04-02 大塚化学株式会社 3支链型糖链天冬酰胺衍生物、该糖链天冬酰胺、该糖链和它们的制造方法
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
PT1591532T (pt) 2003-02-04 2019-01-11 Glytech Inc Processo para produção de um derivado de asparagina de cadeia de açúcar
WO2005010053A1 (ja) 2003-07-28 2005-02-03 Otsuka Chemical Co., Ltd. アミノ化複合型糖鎖誘導体及びその製造方法
JPWO2005095331A1 (ja) 2004-03-31 2008-02-21 塩野義製薬株式会社 糖鎖−ペプチド結合剤
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
TW200643033A (en) 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
TWI342880B (en) 2005-07-19 2011-06-01 Otsuka Chemical Co Ltd Method for producing sugar chain derivatives, and sugar chain derivatives
JPWO2007063907A1 (ja) 2005-11-30 2009-05-07 塩野義製薬株式会社 ペプチド糖鎖付加体およびそれを有効成分とする医薬
MX2009000748A (es) 2006-07-18 2009-03-31 Centocor Inc Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos.
WO2008011633A2 (en) 2006-07-21 2008-01-24 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
DK2172479T3 (en) 2007-06-19 2016-12-19 Glytech Inc GLP-1 peptide having the sugar chain attached thereto

Also Published As

Publication number Publication date
JPWO2009153960A1 (ja) 2011-11-24
WO2009153960A1 (ja) 2009-12-23
AU2009261441A1 (en) 2009-12-23
TWI459960B (zh) 2014-11-11
RU2543157C2 (ru) 2015-02-27
KR101609005B1 (ko) 2016-04-04
RU2011101464A (ru) 2012-07-27
EP2298801A1 (en) 2011-03-23
TW201004643A (en) 2010-02-01
CA2727147A1 (en) 2009-12-23
EP2298801A4 (en) 2011-08-03
US20110195897A1 (en) 2011-08-11
AU2009261441B2 (en) 2013-01-10
CN102083854A (zh) 2011-06-01
JP5604297B2 (ja) 2014-10-08
KR20110031458A (ko) 2011-03-28
US8765669B2 (en) 2014-07-01

Similar Documents

Publication Publication Date Title
BRPI0914889A2 (pt) peptídeo glp-1 adicionado de cadeia oligossacarídica
ATE554786T1 (de) Pegylierte insulin-lispro-verbindungen
DE602009000328D1 (de) Parallelmechanismus
EP3450425C0 (en) PERCARBOXYLIC ACID COMPOSITION
LU92600I2 (fr) Sovaldi (sofosbuvir)
BRPI0905874A2 (pt) Composição fotoprotetora
DK2370461T3 (da) Glucagonanaloger
DE602008003047D1 (de) Heckleuchtenstruktur
DE602006021235D1 (de) Kristallglasgegenstand
DK1849352T3 (da) Mejetærsker
EP2303730A4 (en) SWINGING FEEDER
BRPI0918602A2 (pt) composto (i)
BRPI0908346A2 (pt) beteria
BRPI0907122A2 (pt) Piridoindóis (1-azinona) substituídos
BRPI0913321A2 (pt) transportador de peça
EP2236266A4 (en) Injector
BRPI0915562A2 (pt) tamis melhorado
BRPI0915442A2 (pt) tamis melhorado
DK2278899T3 (da) Bryggemekanisme
FI20070937A0 (fi) Perhekeinu
DE502007006202D1 (de) Kämmmaschine
BRPI0922477A2 (pt) transportador.
DE502007002482D1 (de) Injektor
DE502006007770D1 (de) Transportgeschirrspülmaschine
AT504336B8 (de) Kettenrad

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: GLYTECH, INC. (JP)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL